Correlation analysis showed that patients diagnosed with T3-4 gastric cancer had high expression of MRPS17 (Figure 8C-D, P<0.001), suggesting that MRPS17 is more likely to be highly expressed in advanced or aggressive gastric cancer. Here, MRPS17 is linked to gastric cancer.